The Anatolian Precision Medicine Initiative (APMI) is a flagship project launched by Phenome Longevity in collaboration with Turkiye’s most advanced medical institutions. As one of the most genetically diverse regions in the world, Anatolia offers a uniquely rich landscape for understanding the molecular underpinnings of health and disease. APMI is building an unprecedented multi-omics biobank, setting new standards in personalized medicine, drug discovery, and systems biology.
By harnessing the biological complexity of Anatolia, APMI provides critical insights not only for the region but for the global scientific and clinical communities. The initiative is designed to serve as a blueprint for large-scale precision medicine programmes worldwide; bridging AI, systems biology, clinical data, and multi-omics research.
Eastern Anatolia’s primary academic medical centre
Centre of excellence in molecular biology and transplantation
Turkiye’s largest private medical network with 25+ hospitals
Eastern Anatolia’s primary academic medical centre
Centre of excellence in molecular biology and transplantation
Turkiye’s largest private medical network with 25+ hospitals
All biological samples are processed at SZAOmics, our state-of-the-art Phenome Longevity Multi-Omics Laboratory in Istanbul, Turkiye. Our infrastructure complies with CAP, CLIA, and ISO standards, ensuring the highest level of reproducibility, data quality, and clinical readiness. SZAOmics plays a central role in our multi-omics programmes, serving as the technical backbone of APMI and future cohorts.
Our infrastructure complies with ISO standards, ensuring the highest level of reproducibility, data quality, and clinical readiness. SZAOmics plays a central role in our multi-omics programmes, serving as the technical backbone of APMI and future cohorts.
APMI serves as the pilot cohort of Phenome Longevity’s broader Global 1M-PI—a transformative global programme aimed at generating the largest, most integrated multi-omics dataset in human history. The insights derived from the Anatolian cohort directly inform global expansion strategies across Europe, the United States, and Asia.
APMI serves as the pilot cohort of Phenome Longevity’s broader Global 1 Million Phenome Initiative (1M-PI)—a transformative global programme aimed at generating the largest, most integrated multi-omics dataset in human history. The insights derived from the Anatolian cohort directly inform global expansion strategies across Europe, the United States, and Asia.
APMI serves as the pilot cohort of Phenome Longevity’s broader Global 1 Million Phenome Initiative (1M-PI)—a transformative global programme aimed at generating the largest, most integrated multi-omics dataset in human history. The insights derived from the Anatolian cohort directly inform global expansion strategies across Europe, the United States, and Asia.
APMI serves as the pilot cohort of Phenome Longevity’s broader Global 1 Million Phenome Initiative (1M-PI)—a transformative global programme aimed at generating the largest, most integrated multi-omics dataset in human history. The insights derived from the Anatolian cohort directly inform global expansion strategies across Europe, the United States, and Asia.
APMI serves as the pilot cohort of Phenome Longevity’s broader Global 1 Million Phenome Initiative (1M-PI)—a transformative global programme aimed at generating the largest, most integrated multi-omics dataset in human history. The insights derived from the Anatolian cohort directly inform global expansion strategies across Europe, the United States, and Asia.
A Legacy for Generations
The Anatolian Precision Medicine Initiative is more than a scientific programme—it is a national legacy project designed to elevate Türkiye to the forefront of biomedical innovation. APMI will not only contribute to the global understanding of disease, but will also reshape the future of healthcare delivery in Türkiye by making personalised medicine a clinical reality.
The Anatolian Precision Medicine Initiative is more than a scientific programme—it is a national legacy project designed to elevate Türkiye to the forefront of biomedical innovation. APMI will not only contribute to the global understanding of disease, but will also reshape the future of healthcare delivery in Türkiye by making personalised medicine a clinical reality.
The Anatolian Precision Medicine Initiative is more than a scientific programme—it is a national legacy project designed to elevate Türkiye to the forefront of biomedical innovation. APMI will not only contribute to the global understanding of disease, but will also reshape the future of healthcare delivery in Türkiye by making personalised medicine a clinical reality.